BPT LSE Week ended 31 Jul 2026

Weekly Investor Report

Bridgepoint Group plc · Financial Services · Asset Management

Open interactive chart View report data
Latest close 320.6 GBP
0.9% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 21.0% above the Trend Line and sits at 71.8% of its 52-week range. The latest completed week returned 0.9%, after a 9.5% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers. The latest news-sentiment score is 54/100.

Setup score 54 out of 100
Latest Close 320.6 GBP 31 Jul 2026
1W Return 0.9% latest completed week
4W Return 9.5% short-term follow-through
12W Return 21.3% quarterly tape
Trend Breadth 15.4% 8 of 52 weeks active
Volume Ratio 1.4x vs 13-week average
What is working
  • The trend backdrop is active with a 2-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 43.88% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • Recent volatility is running well above the one-year baseline.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.9% Latest completed week; four-week move 9.5%. Indicator stack 15/90 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 43.88% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 54/100 12 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 21.0% above the Trend Line and sits at 71.8% of its 52-week range. The latest completed week returned 0.9%, after a 9.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4112-week average 0.20

12-week confirmation

Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.41Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 9.5% over four weeks, 21.3% over 12 weeks, and -0.6% over one year. The current trend has remained active for 2 consecutive weeks.

Performance by holding period

1W0.9%
4W9.5%
12W21.3%
26W17.8%
52W-0.6%
Active trend streak2 weeks
Active weeks in one year8
Trend breadth15.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.28Latest activity-pressure read.
Pressure change208.0%Four-week change in activity pressure.
Leadership4.26Latest relative-leadership reading.
RS change184.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 91% Model confidence 74%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength1/100Blend of value, momentum, and quality. Underlying universe rank 100; rank 1 is best.
Value2/100Relative valuation strength. Underlying universe rank 99; rank 1 is best.
Quality9/100Profitability and accounting quality. Underlying universe rank 92; rank 1 is best.
Momentum11/100Medium-term price momentum. Underlying universe rank 90; rank 1 is best.
Growth18/100Revenue and earnings growth. Underlying universe rank 83; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
67.0x
Price divided by trailing earnings.
Price / sales
5.8x
Market value relative to trailing revenue.
EV / EBITDA
31.7x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
1.7%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
60.5%
Gross profit retained from each unit of revenue.
Operating margin
7.0%
Operating profit retained from revenue.
Free-cash-flow margin
21.8%
Free cash flow generated from revenue.
Return on invested capital
0.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
22.6%
Latest one-year revenue growth.
EPS growth
-37.9%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
1211.4%
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
3.0%
Cash dividends relative to market value.
Buyback yield
0.1%
Net share repurchases relative to market value.
Shareholder yield
3.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
16.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment54/100

Weighted news tone is neutral across 12 relevant articles.

3 positive · 9 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-11.7%Distance below the 52-week high.
13-week volatility8.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+25.9%Week of 3 Jul.
Worst week-7.5%Week of 5 Jun.
Latest week+0.9%Week of 31 Jul.

Shape of recent returns

Strong gains3
Modest gains8
Flat weeks0
Modest losses10
Sharp losses5
Recent vol8.2%13-week weekly-return volatility.
Base vol5.8%52-week weekly-return volatility.
Up/down split21/31Count of positive and negative weeks in the 52-week window.
Average skew5.0% / -3.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape47/100

Trend, activity pressure, participation, and risk combine to a 47/100 tape read.

 Indicator analysis46/100

Latest 12-week confirmation: trend 2/12, activity pressure 12/12, relative leadership 3/12.

Activity pressure 0.41; No reversal markers Next-Week ExpectancyNegative 43.88%

Next-week expectancy is negative with a 43.88% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors4/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 41; Small Cap Core rank 97 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment54/100

Weighted news tone is neutral across 12 relevant articles.

Bridgepoint Group shares climb as asset management firm earning jump Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026320.6 GBP0.9%264.9 GBP279.9 GBP1.284.2610.0MOn
24 Jul 2026317.6 GBP-1.5%263.6 GBP279.0 GBP1.244.137.0MOn
17 Jul 2026322.6 GBP12.5%262.5 GBP278.2 GBP0.896.695.4MOff
10 Jul 2026286.8 GBP-2.0%261.2 GBP277.5 GBP0.67-4.707.8MOff
3 Jul 2026292.8 GBP25.9%260.9 GBP276.9 GBP0.41-5.0410.2MOff
26 Jun 2026232.6 GBP-3.6%260.5 GBP276.3 GBP0.19-23.811.5MOff
19 Jun 2026241.4 GBP-1.2%262.2 GBP276.1 GBP0.51-20.558.6MOff
12 Jun 2026244.4 GBP-2.2%263.2 GBP275.8 GBP0.58-20.87803.4KOff
5 Jun 2026249.8 GBP-7.5%264.6 GBP275.6 GBP0.76-18.773.5MOff
29 May 2026270.0 GBP2.8%265.9 GBP275.4 GBP0.86-13.1217.4MOff
22 May 2026262.6 GBP0.6%267.0 GBP275.2 GBP0.66-16.345.1MOff
15 May 2026261.0 GBP-1.3%268.5 GBP274.9 GBP0.57-14.9611.5MOff
8 May 2026264.4 GBP2.9%269.5 GBP274.6 GBP0.46-14.616.8MOff
1 May 2026257.0 GBP-1.9%270.9 GBP274.4 GBP0.03-18.384.5MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.